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Abstract
The quantitative real time polymerase chain reaction (qPCR) has become a key molecular enabling technology with an
immense range of research, clinical, forensic as well as diagnostic applications. Its relatively moderate instrumentation and
reagent requirements have led to its adoption by numerous laboratories, including those located in the Arabian world,
where qPCR, which targets DNA, and reverse transcription qPCR (RT-qPCR), which targets RNA, are widely used for region-
specific biotechnology, agricultural and human genetic studies. However, it has become increasingly apparent that there
are significant problems with both the quality of qPCR-based data as well as the transparency of reporting. This realisation
led to the publication of the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE)
guidelines in 2009 and their more widespread adoption in the last couple of years. An analysis of the performance of
biomedical research in the Arabian world between 2001–2005 suggests that the Arabian world is producing fewer
biomedical publications of lower quality than other Middle Eastern countries. Hence we have analysed specifically the
quality of RT-qPCR-based peer-reviewed papers published since 2009 from Arabian researchers using a bespoke iOS/
Android app developed by one of the authors. Our results show that compliance with 15 essential MIQE criteria was low
(median of 40%, range 0–93%) and few details on RNA quality controls (22% compliance), assays design (12%), RT strategies
(32%), amplification efficiencies (30%) and the normalisation process (3%). These data indicate that one of the reasons for
the poor performance of Arabian world biomedical research may be the low standard of any supporting qPCR experiments
and identify which aspects of qPCR experiments require significant improvements.
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Introduction
The last few years have witnessed a significant growth in
applications for relatively high-throughput techniques such as real
time quantitative PCR (qPCR), microarray analysis and Next
Generation Sequencing (NGS). qPCR in particular has become a
ubiquitous molecular technology, mainly due to its perceived
simplicity, sensitivity, speed and low cost. A ‘‘Web of Knowledge’’
search using the term ‘‘real-time PCR’’ records the use of this
technique in 174,295 publications between 2004 and 2012 in
comparison to only 18,065 articles between 1993 and 2003. Not
surprisingly, this popularity has resulted in a wide range of
different protocols, instruments, assay designs and analysis
methods that have resulted in the publication of data that are
often contradictory and not reproducible[1]. This was the subject
of an editorial in BMC Molecular Biology[2] and was recently
taken up in more general terms in a Nature editorial, which
posited that one of the main problems with data reproducibility is
the lack of scrutiny afforded to the technical detail of publica-
tions[3].
Consequently there has been a growing consensus around the
need to improve the transparency of reporting of relevant
experimental detail to include every aspect important to the
qPCR assay itself, as well as issues relating to pre- and post-assay
parameters. This awareness resulted in the publication of the
MIQE guidelines[4] in 2009, with a follow-up publication
proposing guidelines for digital PCR published earlier this year[5].
These provide a set of recommendations that can be used by
journal reviewers to help them evaluate the reliability of a
publication’s experimental protocols and ensure the inclusion of all
essential technical information in the final publication. Five years
after their publication, the research community is now beginning
to embrace these guidelines, with nearly 2,000 citations recorded
by December 2013 and a recent comparison of publications shows
a significantly improved standard of reporting in papers that cite
the guidelines compared with those that do not[6]. Nevertheless, it
is also important to state that citation of the MIQE publication
does not guarantee actual observance of the guidelines[7] and that
the vast majority of reverse transcription (RT)-qPCR publications
do not comply with even the most basic reporting guidelines[6].
To help with compliance, an iOS/Android app has been
developed for mobile devices, tablet and Personal Computers[8],
with major suppliers providing extensive online advice and
checklists to assist their customers with MIQE compliance (for
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example http://www.roche-applied-science.com/campaigns/
MIQE/).
According to a 2010 report by the UNESCO, the landscape of
Research and Development in the Arabian countries is positively
changing with an increase of almost 45% in the number of
scientific research articles from 2000 to 2008[9]. Several Arabian
countries, especially the Kingdom of Saudi Arabia, Qatar and the
United Arab Emirates, are commissioning cutting-edge research
facilities second to none, for example the Sidra Medical and
Research Center, a world class multi-billion hospital and health
research institute in Qatar or the King Abdulaziz University and
King Abdullah University of Science and Technology in the
Kingdom of Saudi Arabia and several prestigious American and
European universities have developed a presence in the United
Arab Emirates. At the same time an analysis of the performance of
biomedical research in the Arabian world during 2001–2005
suggests that the Arabian world is producing fewer biomedical
publications, which are of lower quality than those from other
Middle Eastern countries[10].
The aim of this analysis was to evaluate the transparency of
reporting of technical detail in peer-reviewed papers published
between 2009 and 2013 that utilised RT-qPCR from the 22
countries of the Arabian league and evaluate whether the technical
standards of these publications has improved.
Methods
RT-qPCR-related articles published by the Arabian countries
were identified as follows (Fig. 1):
N The Scopus database was screened for the terms ‘‘Real time
PCR’’, with all papers included that were published between
2009 and 2013 by authors affiliated to any one of 22 countries
forming the Arabian league. Only articles targeting cellular
RNA were used in the analysis, excluding those targeting viral
RNA.
N Quality and compliance with the MIQE guideline were
analysed based on the criteria shown in Table 1: RNA quality
(two parameters), assays design (three parameters), RT
strategies (three parameters), amplification details (four pa-
rameters) and normalisation (two parameters+ number of
reference genes). Our focus on these 15 criteria, which include
the most critical MIQE parameters, was done for practical
reasons to minimize complexity. They do not imply that the
others can be neglected.
Figure 1. Data analysis method. Eleven steps needed for the analysis of 461 scientific papers related to RT-qPCR.
doi:10.1371/journal.pone.0088266.g001
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Table 1. Quality and compliance with MIQE guideline analysed criteria.
Items Analysed Parameters Method of analysis
Journal Name Impact factor IF is just for information; do not aim for high or low, just for journals that are of interest to you
PubMed ID number NCBI website
Online supplement ‘yes’ if online supplemental file(s) is available
RNA Quality Cellular RNA for this survey we do not want to look at viral RNA
RNA purity ‘yes’ if there is any assessment of purity, through e.g. inhibition assay (SPUD or alike), target and
sample-specific dilution curve, global UV-VIS absorption spectrum, …
RNA integrity ‘yes’, if there is any assessment of integrity, such as microfluidic electrophoresis (Experion,
Bioanalyser, or alike), gel electrophoresis, 59-39 assay, …
Assay details Primer (probe) sequences/assay ID ‘yes’ if primer (and probe) sequences are provided
PCR efficiency ‘yes’ if there is any assessment of amplification efficiency
Assay specificity ‘yes’ if there any mentioning of in silico homology search (BLAST, ePCR, BiSearch, or alike),
amplicon sequencing, restriction digest, amplicon length determination, melting curve, …
Reverse transcription Input amount of RNA in RT reaction ‘yes’ if input amount of RNA in RT reaction is mentioned (also see below)
RT enzyme or RT kit ‘yes’ if there is any mentioning of reverse transcriptase used or specific kit, along with minimal
instructions (can be according to manufacturer)
priming method ‘yes’ if type of primers are mentioned (random primers, oligo-dT, blend, gene specific primers, …)
PCR PCR conditions ‘yes’ if PCR conditions are listed or referred to an older publication
Taq polymerase or PCR kit ‘yes’ if there is any mentioning of Taq polymerase used or specific kit, along with minimal
instructions (can be according to manufacturer)
Final primer concentration ‘yes’ if final primer concentration in reaction is mentioned (or can be deduced)
Input amount template in
PCR reaction
‘yes’ if input amount of template is mentioned; cDNA concentration does not have to be
measured, can be RNA equivalents (e.g. 1 mg of total RNA is reverse transcribed in a 2-step reaction
in 20 ml; 1/10 is used for PCR, which means 5 ng total RNA equivalents gets into PCR reaction)
Normalisation More than 1 reference gene ‘yes’ if more than one reference gene is used
If yes: number of reference genes
Reference gene validation ‘yes’ if there is any indication of reference gene validation method (e.g. geNorm or alike; can also
be referral to previous paper in which their expression stability was validated in similar
experimental conditions)
MIQE Citing the original MIQE Citing the original MIQE paper (Clinical Chemistry 2009)
doi:10.1371/journal.pone.0088266.t001
Figure 2. % compliance with 15 MIQE parameters by all 461 publications between 2009 and 2013. The hatched grey line indicates 50%
compliance.
doi:10.1371/journal.pone.0088266.g002
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N Parameters were recorded as compliant (‘‘1’’) or non-
compliant (‘‘0’’). To calculate compliance for each publication,
individual compliance scores were added to give a maximum
value of 15 (100% compliance). Overall compliance was
determined by calculating the median of these individual
compliance values.
N Compliance for individual parameters was obtained by adding
the scores for the individual publications making up categories
A (impact factor (IF) ,5) or B (IF$5) and expressing them as a
percentage.
N The MIQE app was used to simplify the data collection and all
data were analysed using a Microsoft Excel spreadsheet
(office.microsoft.com). Results are expressed as a percentage
of compliance with individual MIQE criteria. Normalisation
was evaluated by noting the number of reference genes.
N Publications appearing after 2011 were further analysed to
determine whether the quality of the data and transparency of
reporting differed from earlier publications where the authors
might not have been expected to be aware of the MIQE
guidelines. All statistical analyses were carried out using
GraphPad Prism version 6.00 for Mac OS X (GraphPad
Software, San Diego California USA, www.graphpad.com).
Data were tested to determine whether they came from a
normal distribution and appropriate statistical tests were used
for analysis.
Results and Discussion
Transparency of reporting of materials and methods is critical
for reproducibility of RT-qPCR-based experiments, which are
made up of a complex series of steps that remain inadequately
standardised[1]. Hence 461 articles were scrutinized for their
compliance with 15 critical parameters. Overall compliance with
the MIQE guidelines was low, with a median of six out of 15
parameters being reported (range 0-14). There was no significant
difference in compliance with the guidelines between different
regions comprising African Arabian Countries (Algeria, Egypt,
Libya, Morocco, Sudan, and Tunisia), the Kingdom of Saudi
Arabia and the Gulf States/Middle East (Bahrain, Iraq, Jordan,
Kuwait, Lebanon, Oman, Palestine, Qatar and Syria) (Kruskall-
Wallis test, p = 0.424). The recording of RNA integrity, PCR
efficiency and reference gene data was especially inadequate
(Figure 2).
Reporting of RNA quality should involve an assessment of both
its purity (absence of inhibitors) and integrity; only 39% of
publications reported RNA purity and 25% RNA integrity. The
purity data flatter, since they include assessment by spectropho-
Figure 3. Comparison of online supplement utilization and MIQE compliance between publications with IF,5 (grey) and those $5
(black). Both datasets passed the D’Agostino & Pearson and Shapiro&Wilks normality tests, hence the parametric paired t-test was used for data
analysis). The hatched grey line indicates 50% compliance.
doi:10.1371/journal.pone.0088266.g003
Figure 4. Overall compliance with MIQE guidelines of category
A papers (journals with IF,5, n=402) compared to category B
papers (journals with IF.5, n=59). Neither dataset passed the
D’Agostino & Pearson and Shapiro&Wilks normality tests, hence the
nonparametric Mann-Whitney test was used for data analysis).
doi:10.1371/journal.pone.0088266.g004
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tometer, which provides no information on the presence of
potential inhibitors in an RNA preparation. Instead, a comparison
of diluted samples or inclusion of an inhibition control such as the
SPUD assay[11] is advisable. Information about RNA integrity is
also essential since it directly affects the Cq valued recorded by a
sample[12].
An analysis of the assay design criteria, which comprise three
parameters (Table 1) showed that 77% of the papers provided
either the primer sequences or the assay of commercial assays, thus
complying with the modified MIQE criteria[13]. Unfortunately,
PCR efficiency and assay specificity were characterised by
inadequate reporting at 24% and 34%, respectively. Given the
importance of comparing qPCR assays of matching amplification
efficiency and ensuring their specificity, this is unacceptably
low[14].
RT and PCR conditions, represented here by seven parameters,
have a significant impact on cDNA yield and levels of mRNA
expression[15]. Reporting of these parameters was somewhat
higher, although still far from universal and is probably explained
by the fact that their reporting involves no additional validation
work on the part of the authors.
Appropriate normalisation is essential for reliable and biolog-
ically meaningful reporting of RNA expression levels. This
requires the selection of multiple reference genes that have been
properly validated[16]. Unfortunately, the vast majority of
publications use a single reference gene that has not been
validated: only 29 papers normalised the expression of their genes
of interest to two genes, and only 15 papers used more than two
genes. This is very likely to result in conclusions that are not
supported by the actual results but are based on artifacts due to the
inadequate and inappropriate normalisation process[17].
Articles were stratified according to their journal’s IF and
divided into two categories, those published in journals with no IF
or an IF of ,5 (category A, n = 402) and those with IFs of 5 or
above (category B, n= 59). Although only 24% of papers
published in category A journals make use of online supplements,
compared with 68% of those in category B, they report
significantly more experimental detail (Figure 3, paired t-test
p = 0.034), resulting in a negative correlation between IF and
MIQE compliance (Spearman r=20.212, CI 20.3 to 21.12),
p,0.0001). A comparison of overall compliance stratified accord-
ing to IF shows that publications in journals with IF,5 are
significantly more compliant than those in journals with IF $5
(Figure 4, Mann-Whitney p,0.0001). Finally, we compared
publications that appeared between 2009 and 2011 with those
from 2012/13, to determine whether there was any improvement
in transparency of reporting. Figure 5 shows that there is no such
improvement (Mann-Whitney p= 0.798), which suggests either
that the vast majority of Arabian authors are unaware of the
existence of these guidelines or chooses to ignore them.
Only eight publications (2%) cited the 2009 MIQE paper, seven
of which were published in journals with IFs,5. Their standard of
reporting was significantly better than that of those not citing the
MIQE guidelines, with a median compliance of 73% (range 60–
93%, Mann-Whitney p,0.001). However, even here only 2
papers (25%) validated or made use of two or more reference
genes.
Conclusions
We conclude that MIQE awareness in Arabian countries is very
poor and has not improved since 2011, when one might have
expected researchers to become familiar with the concept. This
suggests that much work still needs to be done by Arabian
researchers to implement the transparency criteria advocated by
MIQE guideline. An interesting application of the MIQE
guideline to large-scale clinical and pre-clinical trials showed that
although there was an increase of 4–7% in the cost of qPCR
experiment, no additional time or manpower were needed to
follow the MIQE guideline[18]. Given that the results are likely to
be more reliable, reproducible and clinically relevant, this seems
an appropriate price to pay for better quality data.
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